Leverette (Ethinylestradiol, Levonorgestrel | Lactose)

The combination contains ethynylestradiol, a synthetic estrogen, and levonorgestrel, a progestogen. Ethinylestradiol provides negative feedback to the hypothalamic‑pituitary‑ovarian axis, while levonorgestrel suppresses the luteinizing hormone surge. Together they prevent follicular development, block ovulation, and cause cervical mucus to become less permeable to sperm, thereby preventing pregnancy.

The prescribing physician determines the appropriate dosing schedule for Leverette, which typically follows a daily oral regimen as indicated on the product label. Patients should take the medication exactly as directed by their healthcare provider and should not alter the dose without professional guidance.

Leverette is not intended for use during pregnancy and should be discontinued if pregnancy is confirmed. While limited data exist for breastfeeding, the hormonal components may pass into breast milk; therefore, healthcare providers usually advise caution and assess the risk‑benefit ratio before continuing therapy while nursing.

To order Leverette, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Leverette contains the standard dose range of ethynylestradiol and levonorgestrel found in many combined oral contraceptives, offering comparable efficacy in preventing pregnancy. Its safety profile aligns with other products in the class, though individual tolerability may vary. Choice among alternatives often depends on patient‑specific factors such as side‑effect preferences, cardiovascular risk, and dosing convenience.

Leverette tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the medication out of reach of children and do not use after the expiration date printed on the packaging.

Leverette is taken orally, usually as a single tablet each day at the same time. Patients should swallow the tablet whole with water and follow the dosing schedule prescribed by their healthcare professional, which typically involves a continuous daily regimen for the duration of the treatment cycle.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction, especially in women with pre‑existing risk factors. Rare but severe allergic reactions (anaphylaxis) and significant liver dysfunction have also been reported. Patients should seek immediate medical attention if they experience symptoms like sudden chest pain, shortness of breath, or severe swelling.

Leverette is contraindicated in women who are pregnant, have a known or suspected estrogen‑dependent tumor, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, or are smokers over the age of 35. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.